Orbimed Advisors Llc Sells 281,408 Shares of Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) major shareholder Orbimed Advisors Llc sold 281,408 shares of the stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $45.02, for a total transaction of $12,668,988.16. Following the completion of the transaction, the insider directly owned 245,728 shares of the company’s stock, valued at $11,062,674.56. This trade represents a 53.38% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Bitwise MARA Option Income Strategy ETF Trading Up 1.2%

IMRA opened at $17.23 on Friday. The company’s 50 day moving average is $16.43 and its 200-day moving average is $15.82. Bitwise MARA Option Income Strategy ETF has a 1-year low of $11.99 and a 1-year high of $54.94. The company has a market cap of $3.27 million, a P/E ratio of 344.60 and a beta of 2.88.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.